Orchard nears FDA decision on rare disease gene therapy

[cafead]

via The Food and Drug Administration is reviewing Orchard Therapeutics’ approval application for a gene therapy to treat the rare disease metachromatic leukodystrophy, setting a decision deadline of March 18, 2024, the company said Monday.

article source